Company Profile

PROCTER & GAMBLE HEALTH LTD.

NSE : PGHLBSE : 500126ISIN CODE : INE199A01012Industry : Pharmaceuticals & DrugsHouse : Merck - MNC
BSE3948.6095.6 (+2.48 % )
PREV CLOSE (Rs.) 3853.00
OPEN PRICE (Rs.) 3850.50
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 3948.60 (19 )
VOLUME 1806
TODAY'S LOW / HIGH (Rs.)3839.00 3968.90
52 WK LOW / HIGH (Rs.)2112 4650
NSE3944.00 92.2 (+2.39 % )
PREV CLOSE(Rs.) 3851.80
OPEN PRICE (Rs.) 3818.05
BID PRICE (QTY) 3944.00 (22 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 12058
TODAY'S LOW / HIGH(Rs.) 3818.05 3969.00
52 WK LOW / HIGH (Rs.)2100 5050

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 11.14
TTM EPS (Rs.) 77.19
P/E Ratio 51.15
Book Value (Rs.) 952.33
Face Value (Rs.) 10
MCap (Rs. in Mn) 65544.32
Price/Earning (TTM) 44.80
Price/Sales (TTM) 7.43
Price/Book (MRQ) 4.15
PAT Margin (%) 98.79
ROCE (%) 100.08
Incorporation Year : 1967

Management Info :

Suresh N Talwar - Chairman Milind Thatte - Managing Director

Registered Office :

Address : Godrej One, 8th Floor,Pirojshanagar,Eastern Express Highway, Vikhroli (East),
Mumbai,
Maharashtra-400079

Phone : 022 6210 9000

Website : www.merck.co.in

Registrar's Details : Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS More
29Mar03-29-2019$ Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Compliances-Reg. 39 (3) - D
We have been informed by the shareholder, about the loss /misplacement of the share certificate as detailed in the attachment. We request you to take the same on record and acknowledge the receipt.
We have been informed by the shareholder, about the loss /mispl..
20Mar03-20-2019$ Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Compliances-Reg. 39 (3) - D
We have been informed by the shareholder, about the loss /misplacement of the share certificate as mentioned in the attachment. We request you to take the same on record and acknowledge the receipt.
We have been informed by the shareholder, about the loss /mispl..
20Mar03-20-2019$ Shareholder Meeting / Postal Ballot-Notice of Postal Ballot Shareholder Meeting / Posta
With reference to our letter dated March 1, 2019, we would like to submit the notice of the Postal Ballot with respect to the Company''s proposal of seeking approval of the Members for the following resolution: 1. Continuation of present tenure of directorship of Mr. Suresh Talwar, who is above 75 years of age, as a Non-Executive Independent Director [Special Resolution] Kindly take the above on record and acknowledge the receipt.
With reference to our letter dated March 1, 2019, we would like..
18Mar03-18-2019$ Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Compliances-Reg. 39 (3) - D
We would like to intimate you about issue of duplicate share certificates, as per details in the attachment, on March 15, 2019.
We would like to intimate you about issue of duplicate share ce..
14Mar03-14-2019$ Convening Of 52Nd Annual General Meeting And Book Closure Convening Of 52Nd Annual Ge
We would like to inform you that the 52nd Annual General Meeting of the Company is scheduled to be held on Friday, May 31, 2019. Further to the intimation about the outcome of the Board Meeting dated February 27, 2019 informing exchange about the recommendation of payment of dividend at the rate of Rs. 440/- (Rupees Four Hundred and Forty Only) per equity share of Rs. 10/- each, the Register of Members and the Share Transfer Books of the Company will remain closed from Saturday, May 25, 2019 to Friday, May 31, 2019 (both days inclusive) for the purposes of Annual General Meeting and payment of dividend for the year ended December 31, 2018, if approved by members at the above mentioned Annual General Meeting. Kindly take the same on record.
We would like to inform you that the 52nd Annual General Meetin..
Financials More
Rs. in Millions
QTR Mar 19 ANNUAL 18
Net Profit407.078387.18
Gross Profit 634.93 1579.8
Operating Profit 678.091725.35
Net Sales 2310.38489.95
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Astrazeneca Pharma I (BSE)
 1886.40 (3.32%)
M.Cap ( in Cr)
4716.00
Dr. Reddys Lab (BSE)
 2590.00 (1.54%)
M.Cap ( in Cr)
43021.65
Torrent Pharma (BSE)
 1512.15 (0.97%)
M.Cap ( in Cr)
25586.90
IOL Chem & Pharma (BSE)
 192.05 (3.73%)
M.Cap ( in Cr)
1092.52
Medicamen Biotech (BSE)
 453.15 (1.50%)
M.Cap ( in Cr)
580.78
Shareholding Pattern More
FI/BANKS/INSURANCE 6.36 %
PROMOTERS 51.82 %
NON-INSTITUTION 36.53 %
MUTUAL FUNDS/UTI 1.06 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes

Open A

New Account

Name
Email
Mobile Number
City
Select Products You Are Interested